MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Design Therapeutics, Inc. (DSGN)

Design Therapeutics, Inc. (DSGN)

|||

Balance Sheets Overview

Current Ratio
1886.24%
Quick Ratio
1886.24%
Cash Ratio
114.83%
Debt to Asset Ratio
6.17%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investment securities
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Right-of-use asset
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
12,907
12,770
16,856
15,088
Investment securities
194,489
210,053
202,989
190,882
Prepaid expenses and other current assets
4,617
4,226
3,939
3,059
Total current assets
212,013
227,049
223,784
209,029
Property and equipment
3,266
3,245
3,245
3,212
Less accumulated depreciation
2,572
2,421
2,264
2,108
Property and equipment, net
694
824
981
1,104
Right-of-use asset
2,422
2,569
1,438
1,637
Other assets
-
-
0
0
Total assets
215,129
230,442
226,203
211,770
Accounts payable
3,141
2,276
2,312
1,913
Accrued expenses and other current liabilities (including related party amounts of 890 as of december 31, 2025)
8,099
7,914
10,743
9,260
Total current liabilities
11,240
10,190
13,055
11,173
Operating lease liability
2,031
2,198
645
877
Total liabilities
13,271
12,388
13,700
12,050
Common stock, 0.0001 par value 200,000,000 shares authorized at june 30, 2026 and december 31, 2025 62,580,096 and 60,398,051 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
6
6
6
6
Additional paid-in capital
537,430
532,958
509,100
480,365
Accumulated deficit
-334,807
-314,642
-297,006
-281,009
Accumulated other comprehensive (loss) income
-771
-268
403
358
Total stockholders' equity
201,858
218,054
212,503
199,720
Total liabilities and stockholders' equity
215,129
230,442
226,203
211,770
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investment securities$194,489K (-1.06%↓ Y/Y)Cash and cashequivalents$12,907K (-34.49%↓ Y/Y)Prepaid expenses andother current assets$4,617K (31.24%↑ Y/Y)Property and equipment$3,266K (1.65%↑ Y/Y)Total current assets$212,013K (-3.54%↓ Y/Y)Right-of-use asset$2,422K (32.06%↑ Y/Y)Property and equipment,net$694K (-44.83%↓ Y/Y)Less accumulateddepreciation$2,572K (31.56%↑ Y/Y)Total assets$215,129K (-3.48%↓ Y/Y)Total liabilities andstockholders' equity$215,129K (-3.48%↓ Y/Y)Total stockholders'equity$201,858K (-5.25%↓ Y/Y)Total liabilities$13,271K (34.74%↑ Y/Y)Accumulated deficit-$334,807K (-26.82%↓ Y/Y)Accumulated othercomprehensive (loss) income-$771K (-352.79%↓ Y/Y)Additional paid-in capital$537,430K (12.73%↑ Y/Y)Total currentliabilities$11,240K (28.50%↑ Y/Y)Operating lease liability$2,031K (84.30%↑ Y/Y)Common stock, 0.0001par value...$6K (0.00%↑ Y/Y)Accrued expenses andother current...$8,099K (4.72%↑ Y/Y)Accounts payable$3,141K (210.07%↑ Y/Y)